Standout Papers
Citation Impact
Citing Papers
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
2013
A microbial signature for Crohn's disease
2017
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
2012 Standout
Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation.
2016
Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
2012
Celiac disease: how complicated can it get?
2010
Maintenance treatment of Crohn's disease
2003
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
2010
Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis
2014
Environment and the Inflammatory Bowel Diseases
2013
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Infliximab for acute, not steroid-refractory ulcerative colitis
2004
T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
2012
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
2015
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Cytomegalovirus Colitis Complicating Inflammatory Bowel Disease
2006
The Incidence and Clinical Spectrum of Refractory Celiac Disease in a North American Referral Center
2011
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
1999 Standout
Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
2010
Smoking and Inflammatory Bowel Disease: A Meta-analysis
2006
Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease
2007
Health Maintenance in the Inflammatory Bowel Disease Patient
2012
Adverse Health Effects of Marijuana Use
2014 Standout
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
2015
Geographical variations of inflammatory bowel disease in France: A study based on national health insurance data
2006
Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin–Yang interplay between inflammation and cancer
2010
Pediatric modification of the Montreal classification for inflammatory bowel disease
2010
Ulcerative Colitis
2011 Standout
Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease
2010
Etiology of nonresponsive celiac disease: results of a systematic approach
2002
Meta-analysis of enteral nutrition as a primary treatment of active crohn's disease
1995
Coeliac disease: changing views
2005
Clustering in time of familial IBD separates ulcerative colitis from Crohnʼs disease
2009
Human Genetics Shape the Gut Microbiome
2014 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Long-term Outcome of Treatment with Intravenous Cyclosporin in Patients With Severe Ulcerative Colitis
2004
Incidence of Crohnʼs Disease and Ulcerative Colitis in Rhode Island
2016
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
2013
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates
2010
A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine
2005
AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease
2010
Immunopathogenesis of IBD: current state of the art
2015
Guidelines for the management of inflammatory bowel disease in adults
2011
Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis
2011
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Use of thiopurines in inflammatory bowel disease: Safety issues
2014
Update on the etiology, pathogenesis and diagnosis of ulcerative colitis
2004
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
Antibiotics Associated With Increased Risk of New-Onset Crohn’s Disease But Not Ulcerative Colitis: A Meta-Analysis
2014
Low Colectomy Rates in Ulcerative Colitis in an Unselected European Cohort Followed for 10 Years
2006
The Oslo definitions for coeliac disease and related terms
2012 Standout
Male Issues of the Ileal Pouch
2014
Role of the enteric microbiota in intestinal homeostasis and inflammation
2013
Incidence and Natural Course of Inflammatory Bowel Disease in Korea, 2006–2012
2015
Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database
2006
Ulcerative colitis
2002
Differentiation of Crohnʼs Disease from Intestinal Tuberculosis by Clinical and CT Enterographic Models
2014
Refractory coeliac disease
2005
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Epidemiology and risk factors for IBD
2015 Standout
Structure-guided mutagenesis of a mucin-selective metalloprotease from Akkermansia muciniphila alters substrate preferences
2022 StandoutNobel
Optimizing the safety of biologic therapy for IBD
2010
Inflammatory Bowel Disease
2009 Standout
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population-based cohort followed for ten years
2008
Inflammation and colorectal cancer
2009
European evidenced-based consensus on reproduction in inflammatory bowel disease
2010
Smokers with active Crohnʼs disease have a clinically relevant dysbiosis of the gastrointestinal microbiota*
2011
Celiac Disease
2007 Standout
Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut
2011
Host–microbiota interactions in inflammatory bowel disease
2020
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
2011
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Short Bowel Syndrome and Intestinal Failure in Crohnʼs Disease
2016
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
Inflammatory Bowel Disease and Smoking
2004
CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel Disease
2002
European consensus on the histopathology of inflammatory bowel disease
2013
Ulcerative colitis
2012 Standout
Systematic review: infliximab therapy in ulcerative colitis
2006
The burden of inflammatory bowel disease in Europe
2013
Crohn's disease
2016 Standout
Autophagy in the Pathogenesis of Disease
2008 Standout
Inflammatory Bowel Disease
2002 Standout
Reliability of Antitransglutaminase Antibodies As Predictors of Gluten-Free Diet Compliance in Adult Celiac Disease
2003
The Hygiene Hypothesis: An Explanation for the Increased Frequency of Insulin-Dependent Diabetes
2012
Intestinal mucosal barrier function in health and disease
2009 Standout
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Epidemiology of inflammatory bowel disease
2002
Immunity, Inflammation, and Cancer
2010 Standout
A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease
2012
Autophagy in Human Health and Disease
2013 Standout
Diagnosis of liver fibrosis by transient elastography (FibroScan) and non‐invasive methods in Crohn's disease patients treated with methotrexate
2006
Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients
2011
Certolizumab Pegol for the Treatment of Crohn's Disease
2007
Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue
2001
Clinical Risk Factors for Complicated Disease: How Reliable Are They?
2012
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial management, data analysis, and writing the paper. Maja Noman had a major contribution in the clinical ambulatory follow-up of the patients in the trial. Martin Hiele followed cyclosporine levels and adjusted drug doses of patients in the trial and provided statistical advice. Katrien Asnong was the study coordinator and had a major share in data analysis. Joris Arts analyzed safety data and followed patients clinically during the trial. Andre D’Hoore and Freddy Penninckx performed the surgical interventions in patients failing the trial and substantially contributed in evaluating patients for colectomy.
2003
Medical therapy for ulcerative colitis 2004
2004
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
New Concepts in Intestinal Imaging for Inflammatory Bowel Diseases
2011
Smoking and inflammatory bowel disease
2007
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
2011
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
2006
Ulcerative colitis
2016 Standout
Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
2008
The Risk of Developing Crohn's Disease After an Appendectomy: A Meta-Analysis
2008
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method
2000
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity
2000
Performance of interferon-gamma release assays in patients with inflammatory bowel disease: A systematic review and meta-analysis
2012
Autophagy and Aging
2011 Standout
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Family and twin studies in inflammatory bowel disease
2006
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012
Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
2009
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization
2011
Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis
2009
Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma
2000
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis
2001
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
2009
Incidence of inflammatory bowel disease in Corsica from 2002 to 2003
2007
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Immunosuppressant Medications and Mortality in Inflammatory Bowel Disease
2008
A microbial symbiosis factor prevents intestinal inflammatory disease
2008 StandoutNature
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
2010
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
The Toll-Like Receptor 4 D299G and T399I Polymorphisms Are Associated with Crohn’s Disease and Ulcerative Colitis: A Meta-Analysis
2010
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
2014
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Effects of Current Cigarette Smoking on Clinical Course of Crohn's Disease and Ulcerative Colitis
2001
Enteropathy associated T-cell lymphoma and its precursor lesions
2010
Classification and management of refractory coeliac disease
2010
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Successive Treatment With Cyclosporine and Infliximab in Steroid-Refractory Ulcerative Colitis
2011
Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease
1994
Preclinical disease and preventive strategies in IBD: perspectives, challenges and opportunities
2016
Defining gluten refractory enteropathy
2001
Basiliximab (anti‐CD25) in combination with steroids may be an effective new treatment for steroid‐resistant ulcerative colitis
2003
Risk factors and characteristics of extent progression in ulcerative colitis
2009
First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?
2013
The global burden of IBD: from 2015 to 2025
2015 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Biologic agents for IBD: practical insights
2015
The Spectrum of Perianal Crohn’s Disease in a Population-Based Cohort
2012
The Link between the Appendix and Ulcerative Colitis: Clinical Relevance and Potential Immunological Mechanisms
2015
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease
2016
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease
2006
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
Highlighting new phylogenetic specificities of Crohnʼs disease microbiota
2010
Passive Smoking and Inflammatory Bowel Disease: A Meta-Analysis
2008
Fine-scale geographic variations of inflammatory bowel disease in France: Correlation with socioeconomic and house equipment variables
2009
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia
2015
Methotrexate for induction of remission in refractory Crohn's disease
2014
Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease
2016
Mucosal Intra-epithelial Lymphocytes in Enteropathy-Associated T-Cell Lymphoma, Ulcerative Jejunitis, and Refractory Celiac Disease Constitute a Neoplastic Population
1999
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
2012
Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort
2014
Aspirin, Nonsteroidal Anti-inflammatory Drug Use, and Risk for Crohn Disease and Ulcerative Colitis
2012
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Methotrexate for maintenance of remission in Crohn's disease
2014
Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution
2005
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
2005 StandoutScience
Concordance of Inflammatory Bowel Disease among Danish Twins: Results of a Nationwide Study
2000
Enteral nutritional therapy for induction of remission in Crohn's disease
2007
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
The ecology of the microbiome: Networks, competition, and stability
2015 StandoutScience
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort
2013
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
2015
Cancers Complicating Inflammatory Bowel Disease
2015
A validated web‐based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables
2015
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
2011
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease
2013
Works of Jacques Cosnes being referenced
Crohn’s disease severity in familial and sporadic cases
1999
Fungal microbiota dysbiosis in IBD
2016
Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study
1999
The Role of Anatomic Factors in Nutritional Autonomy After Extensive Small Bowel Resection
1996
Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis
2008
Infliximab for refractory ulcerative colitis or indeterminate colitis: an open‐label multicentre study
2003
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
2008
Incidence of Autoimmune Diseases in Celiac Disease: Protective Effect of the Gluten-Free Diet
2008
Effects of light smoking consumption on the clinical course of Crohnʼs disease
2008
Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice
2004
Risk Factors Associated With Small Bowel Adenocarcinoma in Crohn's Disease: A CaseControl Study
2008
Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis
2007
Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy
2010
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
2013
Intravenous cyclosporine in attacks of ulcerative colitis
1996
Smoking cessation and the course of Crohn's disease: An intervention study
2001
Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine
2010
Predictive Factors of Eczema-Like Eruptions among Patients without Cutaneous Psoriasis Receiving Infliximab: A Cohort Study of 92 Patients
2009
Gender differences in the response of colitis to smoking
2004
Predictors of Crohn’s Disease
2006
Impact of pregnancy on the clinical activity of Crohn's disease
2005
Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery
2005
Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I With Type II
2008
Risk Factors for Neoplasia in Inflammatory Bowel Disease Patients With Pancolitis
2010
Significance of Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel Diseases
2008
Small Bowel Adenocarcinoma in Patients with Crohnʼs Disease Compared with Small Bowel Adenocarcinoma De Novo
2005
What is the link between the use of tobacco and IBD?
2008
Methotrexate in Crohn's Disease: Long-Term Efficacy and Toxicity
2000
Crohn's disease clinical course and severity in obese patients
2002
Current smoking differentially affects blood mononuclear cells from patients with crohnʼs disease and ulcerative colitis: Relevance to its adverse role in the disease
2011
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
2009
Review article: smoking cessation as primary therapy to modify the course of Crohn's disease
2005
Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease
2014
Factors affecting outcomes in Crohn's disease over 15 years
2012
Prior appendectomy and the phenotype and course of Crohn’s disease
2006
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Long-term Outcome of Patients With Crohn's Disease Who Respond to Azathioprine
2012
Impact of cessation of smoking on the course of ulcerative colitis
2001
Effects of appendicectomy on the course of ulcerative colitis
2002
Smoking, Physical Activity, Nutrition and Lifestyle: Environmental Factors and Their Impact on IBD
2010
Definition and Diagnosis of Cytomegalovirus Colitis in Patients Infected by Human Immunodeficiency Virus
1997
Effects of cigarette smoking on the long-term course of Crohn's disease
1996
Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet.
1991
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohnʼs disease
2009
Sa1118 Withdrawing or Continuing Maintenance Treatment With Thiopurines in Patients With Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis
2015
Crohn's disease over 20 years after diagnosis in a referral population
2004
Long-Term Evolution of Disease Behavior of Crohn's Disease
2002 Standout
Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
2015
Specific Clinical and Biological Features Characterize Inflammatory Bowel Disease–Associated Colorectal Cancers Showing Microsatellite Instability
2007
943c ACCELERATED STEP-CARE THERAPY WITH EARLY AZATHIOPRINE (AZA) VS. CONVENTIONAL STEP-CARE THERAPY IN CROHN'S DISEASE. A RANDOMIZED STUDY.
2012
[Effect of smoking on the long-term course of ulcerative colitis].
1998
The Enteropathy Associated With Common Variable Immunodeficiency: The Delineated Frontiers With Celiac Disease
2010
Methotrexate in Crohn?s disease: long-term efficacy and toxicity
2000
[Exclusive elemental enteral diet in cortico-resistant and cortico-dependent forms of Crohn's disease].
1987
Are Complicated Forms of Celiac Disease Cryptic T-Cell Lymphomas?
1998
S1095 Withdrawal of Immunosuppression in Inflammatory Bowel Disease Treated with Infliximab Maintenance Therapy
2009
[Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
2002
What is the link between the use of tobacco and IBD?
2008
Crohn's disease phenotype, prognosis, and long-term complications: what to expect?
2008
Anti-TNF Therapy and Pregnancy in Inflammatory Bowel Disease: A Prospective Cohort Study From the GETAID
2011